74 related articles for article (PubMed ID: 6169557)
1. Natural killer cell cytotoxic potential of patients with ovarian carcinoma and its modulation with virus-modified tumor cell extract.
Lotzová E; Savary CA; Freedman RS; Bowen JM
Cancer Immunol Immunother; 1984; 17(2):124-9. PubMed ID: 6205745
[TBL] [Abstract][Full Text] [Related]
2. Natural cytotoxicity in lymphatic metastasis. I. In vitro studies using the rat tumor BSp73 and its variants.
Matzku S; Oberneder HP; Keller R; Zöller M
Cancer Immunol Immunother; 1984; 17(2):100-5. PubMed ID: 6565516
[TBL] [Abstract][Full Text] [Related]
3. Natural cytotoxicity in lymphatic metastasis. II. In vivo studies with BSp73 variants differing in metastatic capacity.
Matzku S
Cancer Immunol Immunother; 1984; 17(2):106-11. PubMed ID: 6565517
[TBL] [Abstract][Full Text] [Related]
4. The immunomodulatory-drug, lenalidomide, sustains and enhances interferon-α production by human plasmacytoid dendritic cells.
Kibata K; Ito T; Inaba M; Tanaka A; Iwata R; Inagaki-Katashiba N; Phan V; Satake A; Nomura S
J Blood Med; 2019; 10():217-226. PubMed ID: 31372079
[No Abstract] [Full Text] [Related]
5. Friend retrovirus studies reveal complex interactions between intrinsic, innate and adaptive immunity.
Dittmer U; Sutter K; Kassiotis G; Zelinskyy G; Bánki Z; Stoiber H; Santiago ML; Hasenkrug KJ
FEMS Microbiol Rev; 2019 Sep; 43(5):435-456. PubMed ID: 31087035
[TBL] [Abstract][Full Text] [Related]
6. The RNA binding protein La/SS-B promotes RIG-I-mediated type I and type III IFN responses following Sendai viral infection.
Mahony R; Broadbent L; Maier-Moore JS; Power UF; Jefferies CA
Sci Rep; 2017 Nov; 7(1):14537. PubMed ID: 29109527
[TBL] [Abstract][Full Text] [Related]
7. IFN-α subtypes: distinct biological activities in anti-viral therapy.
Gibbert K; Schlaak JF; Yang D; Dittmer U
Br J Pharmacol; 2013 Mar; 168(5):1048-58. PubMed ID: 23072338
[TBL] [Abstract][Full Text] [Related]
8. Interferon-alpha subtype 11 activates NK cells and enables control of retroviral infection.
Gibbert K; Joedicke JJ; Meryk A; Trilling M; Francois S; Duppach J; Kraft A; Lang KS; Dittmer U
PLoS Pathog; 2012; 8(8):e1002868. PubMed ID: 22912583
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of immune responses to porcine reproductive and respiratory syndrome virus in pigs during early stage of infection under farm conditions.
Dwivedi V; Manickam C; Binjawadagi B; Linhares D; Murtaugh MP; Renukaradhya GJ
Virol J; 2012 Feb; 9():45. PubMed ID: 22340040
[TBL] [Abstract][Full Text] [Related]
10. Alpha interferon as an immunomodulator in the treatment of patients with tumors.
Alvarez-Mon M; Salmerón OJ; Manzano L; Rodríguez-Zapata M; Reyes E; Vaquer LM; Carballido J
Med Oncol; 1995 Mar; 12(1):15-21. PubMed ID: 8542242
[No Abstract] [Full Text] [Related]
11. Prostaglandin E2 depresses natural cytotoxicity by inhibiting interleukin-1 production by large granular lymphocytes.
Herman J; Rabson AR
Clin Exp Immunol; 1984 Aug; 57(2):380-4. PubMed ID: 6331926
[TBL] [Abstract][Full Text] [Related]
12. Interferon enhancement of the invasive capacity of Ewing sarcoma cells in vitro.
Siegal GP; Thorgeirsson UP; Russo RG; Wallace DM; Liotta LA; Berger SL
Proc Natl Acad Sci U S A; 1982 Jul; 79(13):4064-8. PubMed ID: 6180434
[TBL] [Abstract][Full Text] [Related]
13. Natural killer (NK) cell immunodeficiency in patients with chronic myelogenous leukemia. II. Successful cloning and amplification of natural killer cells.
Fujimiya Y; Chang WC; Bakke A; Horwitz D; Pattengale PK
Cancer Immunol Immunother; 1987; 24(3):213-20. PubMed ID: 3496152
[TBL] [Abstract][Full Text] [Related]
14. Defects of natural killer cell activity in children with untreated acute lymphocytic leukemia.
Gabrilovac J; Boranić M; Kusić B; Batinić D; Rajić L; Tiefenbach A
Klin Wochenschr; 1988 Apr; 66(8):354-60. PubMed ID: 3164791
[TBL] [Abstract][Full Text] [Related]
15. Defective interleukin-1 production by natural killer cells of patients with cancer.
Herman J; Kew MC; Rabson AR
Cancer Immunol Immunother; 1985; 19(2):148-53. PubMed ID: 2985238
[TBL] [Abstract][Full Text] [Related]
16. Biology of natural killer cells.
Trinchieri G
Adv Immunol; 1989; 47():187-376. PubMed ID: 2683611
[TBL] [Abstract][Full Text] [Related]
17. Antagonistic effects of interferons on the cytotoxicity mediated by natural killer cells.
Trinchieri G; Santoli D; Granato D; Perussia B
Fed Proc; 1981 Oct; 40(12):2705-10. PubMed ID: 6169557
[TBL] [Abstract][Full Text] [Related]
18. Interferon-induced resistance of fibroblasts to cytolysis mediated by natural killer cells: specificity and mechanism.
Trinchieri G; Granato D; Perussia B
J Immunol; 1981 Jan; 126(1):335-40. PubMed ID: 7451975
[TBL] [Abstract][Full Text] [Related]
19. Cell-mediated cytotoxicity against virus-infected target cells in humans. II. Interferon induction and activation of natural killer cells.
Santoli D; Trinchieri G; Koprowski H
J Immunol; 1978 Aug; 121(2):532-8. PubMed ID: 150448
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
